Which of the following is considered a source document?
Answer(s): D
Source documents are the original records where trial data are first recorded, from which Case Report Form (CRF) entries are verified.ICH E6(R2) 1.52: Defines source documents as "original documents, data, and records (e.g., hospital records, clinical and office charts, laboratory notes, pharmacy dispensing records, recorded data from automated instruments, etc.)."ICH E6(R2) 8.3.13: Requires maintenance of "source documents" to verify data integrity and allow monitoring/audits.Pharmacy dispensing records (D) fit this definition, as they show initial data on investigational product dispensing and accountability. In contrast, subject instruction sheets (A) are communication tools, SOPs (B) are procedural guides, and the protocol (C) is a governing document, none of which qualify as original data records.Therefore, the correct answer is D (Pharmacy dispensing records).
ICH E6(R2), §1.52 (Definition of source documents).ICH E6(R2), §8.3.13 (Source documents in essential documentation).
A nonrandomized study of 30 subjects entitled "A study to evaluate the effectiveness of and to determine the common short-term side effects associated with the drug 'PainStop' for the treatment of subjects with chronic arthritis" is an example of a:
Answer(s): B
Phase classification is based on study objectives, not just subject numbers.Phase I: Focuses on safety, pharmacokinetics, dose-ranging, usually in healthy volunteers or small patient groups.Phase II: Evaluates effectiveness in patients with the condition and monitors common short-term side effects.Phase III: Confirms effectiveness in larger populations, compares to standard therapy, gathers more safety data.Phase IV: Post-marketing studies exploring new indications, long-term safety, or special populations.The given study aims to evaluate effectiveness and common short-term side effects in 30 arthritis patients, which clearly aligns with Phase II objectives. It is not exploratory safety (Phase I), not confirmatory comparative (Phase III), nor post-marketing (Phase IV).Thus, the correct answer is B (Phase II).
FDA Guidance: The IND Application -- §312.21 (Phases of an investigation).ICH E8(R1), General Considerations for Clinical Studies.
Which document was created by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research and summarizes the basic ethical principles and guidelines for the conduct of research involving human subjects?
The Belmont Report (1979), issued by the U.S. National Commission, identifies three core ethical principles guiding human subject research:Respect for Persons (informed consent, autonomy, protection of vulnerable populations).Beneficence (maximize benefits, minimize harms).Justice (fairness in subject selection and treatment).The Nuremberg Code (1947) was developed post-WWII to prevent unethical experiments.The Declaration of Helsinki (1964, updated) is a World Medical Association document guiding international physician research ethics.The ICH Guidelines (1996) outline harmonized regulatory requirements for good clinical practice.Only the Belmont Report fits the description of a U.S.-based, principle-driven framework for human research ethics.Thus, the correct answer is D (The Belmont Report).
The Belmont Report (1979), National Commission for the Protection of Human Subjects.45 CFR 46 (Human Subject Protections).
A pharmaceutical company is developing a biologic study. In accordance with ICH, which of the following items should be included in an investigator's brochure (IB)?
The Investigator's Brochure (IB) compiles clinical and nonclinical data on an investigational product relevant to human study.ICH E6(R2) 7.2.3: The IB should summarize nonclinical pharmacology, toxicology, pharmacokinetics, and efficacy data, including results of animal studies.ICH E6(R2) 7.2.4: It should also include available clinical trial data and safety experience.The "results of recent nude mouse study" (B) are nonclinical data, which appropriately belong in the IB. Lab draw requirements (A), dispensing instructions (C), and schedules of events (D) are operational/procedural and are found in the protocol, not the IB.Thus, the correct answer is B (Results of recent nude mouse study).
ICH E6(R2), §7.2.37.2.4 (Contents of Investigator's Brochure).
Which of the following would be considered an addendum to an investigator's brochure for an unapproved Investigational Product?
The IB must be updated as new significant safety information emerges.ICH E6(R2) 7.3: "The sponsor should revise the IB as soon as new, significant information becomes available."ICH E2A: Requires sponsors to report Suspected Unexpected Serious Adverse Reactions (SUSARs) in expedited reports and include them in IB updates or addenda.A SUSAR report (B) represents new, unexpected, and serious safety information not previously documented, and therefore warrants inclusion as an IB addendum until the IB is formally updated.Revised consent forms (A) are submitted to IRBs, not IBs. Site-specific SAE reports (C) remain at site/sponsor level, not in the IB. Product monograph updates (D) apply to approved products, not investigational ones.Thus, the correct answer is B (SUSAR report).
ICH E6(R2), §7.3 (Updating the Investigator's Brochure).ICH E2A (Clinical Safety Data Management: Definitions and Standards for Expedited Reporting).
Post your Comments and Discuss SOCRA CCRP exam prep with other Community members:
Our website is free, but we have to fight against AI bots and content theft. We're sorry for the inconvenience caused by these security measures. You can access the rest of the CCRP content, but please register or login to continue.